Peggy Scherle - Net Worth and Insider Trading
Peggy Scherle Net Worth
The estimated net worth of Peggy Scherle is at least $198,858 dollars as of 2024-11-13. Peggy Scherle is the Chief Scientific Officer of Prelude Therapeutics Inc and owns about 172,920 shares of Prelude Therapeutics Inc (PRLD) stock worth over $198,858. Details can be seen in Peggy Scherle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peggy Scherle has not made any transactions after 2021-08-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peggy Scherle
Peggy Scherle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peggy Scherle owns 1 companies in total, including Prelude Therapeutics Inc (PRLD) .
Click here to see the complete history of Peggy Scherle’s form 4 insider trades.
Insider Ownership Summary of Peggy Scherle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2021-08-27 | Chief Scientific Officer |
Peggy Scherle Latest Holdings Summary
Peggy Scherle currently owns a total of 1 stock. Peggy Scherle owns 172,920 shares of Prelude Therapeutics Inc (PRLD) as of August 27, 2021, with a value of $198,858.
Latest Holdings of Peggy Scherle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2021-08-27 | 172,920 | 1.15 | 198,858 |
Holding Weightings of Peggy Scherle
Peggy Scherle Form 4 Trading Tracker
According to the SEC Form 4 filings, Peggy Scherle has made a total of 6 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Prelude Therapeutics Inc is the sale of 7,714 shares on August 27, 2021, which brought Peggy Scherle around $275,776.
Insider Trading History of Peggy Scherle
- 1
Peggy Scherle Trading Performance
Peggy Scherle Ownership Network
Ownership Network List of Peggy Scherle
Ownership Network Relation of Peggy Scherle
Peggy Scherle Owned Company Details
What does Prelude Therapeutics Inc do?
Who are the key executives at Prelude Therapeutics Inc?
Peggy Scherle is the Chief Scientific Officer of Prelude Therapeutics Inc. Other key executives at Prelude Therapeutics Inc include director & President & CEO Krishna Vaddi , Chief Legal Counsel & Corp Sec. Bryant David Lim , and Chief Financial Officer Laurent Chardonnet .
Prelude Therapeutics Inc (PRLD) Insider Trades Summary
Over the past 18 months, Peggy Scherle made no insider transaction in Prelude Therapeutics Inc (PRLD). Other recent insider transactions involving Prelude Therapeutics Inc (PRLD) include a net purchase of 13,756 shares made by Krishna Vaddi , a net purchase of 869,565 shares made by Orbimed Advisors Llc , and a net purchase of 869,565 shares made by David P Bonita .
In summary, during the past 3 months, insiders sold 0 shares of Prelude Therapeutics Inc (PRLD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prelude Therapeutics Inc (PRLD) were sold and 1,760,286 shares were bought by its insiders, resulting in a net purchase of 1,760,286 shares.
Prelude Therapeutics Inc (PRLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prelude Therapeutics Inc Insider Transactions
Peggy Scherle Mailing Address
Above is the net worth, insider trading, and ownership report for Peggy Scherle. You might contact Peggy Scherle via mailing address: C/o Prelude Therapeutics Incorporated, 200 Powder Mill Road, Wilmington De 19803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
